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Bacterial Chondronecrosis with Osteomyelitis (BCO) is a debilitating infection that negatively 
impacts animal welfare and costs the broiler industry billions of dollars annually. We have 
previously isolated Staphylococcus agnetis 908 from BCO samples obtained from broilers at the 
University of Arkansas research farm. This isolate can induce BCO lameness at greater than 
50% in broilers exposed to the pathogen in drinking water. We found that S. agnetis 908 is 
capable of surviving and escaping macrophages compared to a closely related cattle isolate, 
1379. Through Directed Genome Evolution (DGE) we identified that this difference is at least 
partially associated with an alanine to glutamate substitution for residue 164 of the enzyme 
deoxyribose phosphate aldolase (a.k.a. deoC, DERA). This study further explores whether 
A164E in deoC is responsible for enhanced survival and escape of S. agnetis 908 from 
macrophages. S. agnetis 1379 was transformed with the PCR products of the 908 deoC1 and 
deoC2 paralogs. The resulting transformants were cocultured with chicken macrophage-like 
cells in standard phagocytosis assays for DGE. The survivors were characterized for sequence 
changes in deoC through PCR sequencing. In addition, we investigated the effect of the A164E 
on host-cell damage by utilizing gentamicin protection assays in tandem with crystal violet 
staining. We evaluate the drawbacks of the gentamicin protection assay and evaluated an 
alternative enzyme protection assay. The crystal violet staining revealed that 908 and the 
transformant of 1379 inflicted more cellular damage. The enzyme protection assay was superior 
to gentamicin protection and indicated that there were no significant differences in the damage 
to HTCs caused by the different bacterial strains. 
Identification of the bacterial virulence factors important to the infection process, and how these 
interact with the host immune responses are important in devising management plans for 
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1.1. Bacterial Chondronecrosis with Osteomyelitis 
The poultry industry which consists of broilers, eggs, and domesticated birds such as 
turkeys, ducks, quail and pheasants is a billion-dollar industry in the United States alone (USDA, 
National Agricultural Statistics Service, 2021). The broiler industry depends on selective 
breeding of chickens (Gallus gallus domesticus) for meat production. When the broiler industry 
first started out in the 1920s it took 16 weeks to obtain an adult chicken of 1.1 kg (Aho, 2002, 
National Chicken Council, 2021). The expansion of the broiler industry was driven by production 
of high yielding birds through selective breeding (Bradshaw et al., 2002).  At present, a typical 
broiler chicken weighs approximately 4.5 kg as result of selective breeding for early rapid growth 
rate. This improvement is a nearly 300% increase from gaining 25 g per day to gaining 100 g 
per day (Knowles et al., 2008).  
With the domestication of chickens, the genetic diversity of the species has considerably 
decreased through inbreeding, creating a genetic drift through selection (Elferink et al., 2012). 
Selection for an advantageous gene may also have negative consequences. Selection for a 
beneficial trait in one gene can result in a selective sweep of “neutral” genes in flanking regions 
in a process called ‘hitch-hiking’. Others have hypothesized that hitch hiking has resulted in 
producing high-yielding birds with several negative traits such as decreased resistance to 
infectious disease (Zekarias et al., 2002), increased skeletal deformities (Julian, 1998), 
osteoporosis (Whitehead and Fleming, 2000) and pulmonary hypertension syndrome 
(Baghbanzadeh and Decuypere, 2008, Balog, 2003, Wideman et al., 2013b).  
The rapid growth rate observed in broilers compared to the layers (for egg production) 




2000, Wideman, 2016). With increasing muscle mass, the chicken skeletal system must also 
have concomitant increases  (Thorp et al., 1993, Riddell and Springer, 1985, Williams et al., 
2000, Wideman, 2016, Rhoads and Wideman, 2020). The femora and tibia undergo a four-fold 
increase in length along with a three-to-five-fold increase in mid-shaft diameter over the course 
of the first six weeks (Applegate and Lilburn, 2002). However, it is evident that skeletal 
development does not sufficiently compensate for the increase in muscle mass as the incidence 
of lameness is reduced when the growth rate of chicken was reduced. 
 Lack of sufficient skeletal development is not the sole cause of lameness. Bone defects 
such as tibial dyschondroplasia (TD) (Leach and Nesheim, 1965), angular limb deformities  
(Julian, 1984), arthritis and osteomyelitis (Riddell & Springer, 1985) further aggravate the 
problem. However, currently Bacterial Chondronecrosis and Osteomyelitis (BCO) has been 
identified as the most common cause of lameness among commercial broiler chicken 
(McNamee et al., 1998, Thorp and Waddington, 1997, Mitchell, 2014, Wideman, 2016). BCO 
has been identified using various terminologies including: osteomyelitis, femoral head necrosis, 
long bone necrosis, proximal femoral degeneration, bacterial chondritis with osteomyelitis 
(McNamee and Smyth, 2000). However, BCO is most fitting since it considers the infection in 
the growth plate cartilage and the bacterial aetiology of the disease.  
BCO was first reported as a cause of lameness in commercial broiler chickens in 
Australia (Nairn and Watson, 1972). Subsequently, countries such as US, Canada and Europe 
have also reported this condition in broilers (Riddell & Springer, 1985; Thorp et al., 1993; Thorp 
& Waddington, 1997; McNamee et al., 1998). Thorp et al. (1993) investigated birds in the UK 
suspected to have lesions in the hip but showed a high incidence of BCO. BCO was also a 
common diagnosis in lame birds examined by Thorp & Waddington (1997). BCO was identified 
to be the most common cause of lameness in commercial birds through systematic large-scale 




continues to remain the most frequent form of lameness in the US broiler industry (Wideman, 
2016, Mitchell, 2014). 
1.1.1. Factors contributing to BCO. 
In addition to the increased growth rate and skeletal deformities, a multitude of other 
factors contribute to BCO. One such factor is immunosuppression (Mutalib et al., 1983, 
Andreasen et al., 1993, McNamee et al., 1998, Wideman et al., 2013a, Butterworth, 1999). As 
described by McNamee and Smyth (2000) by infecting a bird with chicken anemia virus and 
infectious bursal disease led to an increased incidence of BCO while reducing the feed intake 
decreased its incidence. Additionally, environmental stresses such as competition induced by 
social pressure can lead to compromised immunity (Wideman et al 2013) and chronic stress 
caused by the lack of accessibility to floor-litter has been shown to induce immunosuppression 
with increased blood corticosterone levels (El-Lethey et al., 2003). Additionally, male broilers are 
more likely to develop BCO due to the fast growth rate compared to slower growing female 
counterparts (Wideman et al., 2013).  
Bacterial infections are a major risk factor for the development of BCO. Bacteria in the 
breeding farm and the hatchery are potential sources for bacterial infections (McNamee ad Smyth 
2000). Pulse field gel electrophoresis had confirmed this by tracing naturally Staphylococcus 
aureus infection in chicken to bacteria isolated from fluff debris from hatcheries. Furthermore, 
birds hatched from floor eggs were identified as being more susceptible to BCO which could be 
due to the transmission of poultry strains of S. aureus from humans to chickens (McCullagh et al., 
1998).   
1.1.2. Pathogenesis of BCO 
Bacteria in the environment can enter the chicken blood stream through the respiratory 




blood circulation, bacteria that can survive are able to distribute hematogenously and enter the 
bone marrow vasculature (Wideman, 2016). BCO is most likely to affect the proximal growth 
plates of the femora and tibiae of broilers. This is due to the combination of possessing 
abnormally long, unevenly aligned chondrocytes paired with thicker proximal growth plates of 
birds which lead to higher growth plate turnover during longitudinal growth. Thus, the proximal 
ends of the leg bones grow faster and are thicker than other species (Church and Johnson, 
1964, Leach and Nesheim, 1965, Thorp et al., 1993, Kember et al., 1990, Kirkwood et al., 
1989). Torque and physical stress exerted on these bones results in microfractures called 
osteochondrotic clefts. These microfractures may result in damaged blood vessels resulting in 
ischaemia leading to regions of necrosis. Bacteria in the bone marrow vasculature colonize 
these osteochondrotic clefts resulting in necrotic regions, i.e., osteomyelitis. Bacteria residing in 
these locations are inaccessible to immune responses and antibiotics thus harder to 
eliminate(Thorp and Waddington, 1997, McNamee et al., 1998, McNamee and Smyth, 2000). 
Figure 1. Pathogenesis of BCO describing the possible portals of entry of bacteria and 





1.1.3. BCO as an animal welfare and economic issue 
Lameness compromises mobility of the bird which decreases its quality of life (reduced 
animal well-being). Immobile birds are unable to perform their routine activities such as 
dustbathing foraging, preening or walking to access food and water (Vestergaard and Sanotra, 
1999, Weeks et al., 2000, Butterworth, 1999). Multiple studies concluded that birds with 
lameness feel pain as shown by McGeown et al. (1999) the birds preferring food with analgesics 
and performing better after a period of time while others state that there is no relationship 
between lameness and pain (Caplen et al., 2013, Danbury et al., 2000).  
Based on data recorded daily and from weekly necropsy examination of birds from 51 
broiler flocks in Western Canada, Riddell & Springer (1985) found the incidence of birds culled 
due to lameness ranged from 0.46 to 4.08%. In this study, the average incidence of chickens 
with skeletal deformities was 1.72%, which included 1.1% chickens culled in the field and 0.62% 
chickens condemned at processing (McNamee and Smyth, 2000). In 1993, a national survey in 
the US estimated that leg problems cost the broiler industry between 80 and 120 million dollars 
annually (Morris, 1993). As of present, BCO costs the broiler industry over a billion dollars 
annually (Rojas-Nunez et al., 2020).  
1.1.4. Clinical signs of BCO 
Previous studies have shown that an increase in lameness is usually accompanied by 
increased mortality rates (Nairn and Watson, 1972, Griffiths et al., 1977). Living birds with BCO 
would display a limping gait, hip flexion and would indicate pain by vocalizing loudly when 
pressure is exerted to the affected regions (Thorp et al., 1993, Mutalib et al., 1983). Other 
clinical signs include ruffled feathers, reluctance to walk, having their heads down, closed eyes, 
sitting on their hocks, and weak response to external stimuli (McNamee and Smyth, 2000) 




Rubaye et al. (2015) reported that birds with lameness were not overtly detectable until 19 days 
post-inoculation with bacteria. Reticence to move was a common sign observed toward the 
latter stages of the disease (Nairn & Watson, 1972) As a result of this, weight loss is yet another 
identifiable marker of both naturally and experimentally induced lame birds (McNamee and 
Smyth, 2000). 
1.1.5. BCO and bacteria 
Bacteria are inevitably present in the environment, from drinking water to the air inside the 
facility. DNA for a diverse bacterial population was isolated from macroscopically healthy 
proximal femoral and tibial heads of presumably healthy chicken (Jiang et al., 2015).  Thus, it is 
evident that bacteria can enter chicken blood circulation and distribute hematogenously even 
among healthy birds. This study identified Proteobacter as the most common species isolated 
from both femoral and tibial samples of healthy birds, followed by Firmicutes and actinobacter. 
Similar findings were reported in a study by (Mandal et al., 2016). Yet, a study by (Danzeisen et 
al., 2011) had identified Firmicutes to be the most abundant organisms isolated from cecum 
samples which indicates Firmicutes would have been more prevalent. However, it should be 
noted that Proteobacter has a higher potential to survive and spread hematogenously, crossing 
the gastrointestinal epithelium which could explain the prevalence of Proteobacter. Jiang et al. 
(2015), further reported that there were distinctive differences in the microbial population 
between healthy femoral and tibial samples and samples obtained from BCO infected chicken. 
Additionally, the femoral and tibial samples did not yield the same bacterial populations and 
bacteria isolated from the different lesions including normal, Femoral Head Separation, Femoral 
Head Necrosis, Tibial Head Necrosis, and Tibial Head Necrosis severe or caseous were 
significantly different from each other.   
Several studies on BCO have identified Staphylococcus aureus, Escherichia coli, 




causative agents of BCO (McNamee and Smyth, 2000, Wideman and Prisby, 2012, Jiang et al., 
2015). However, a study by Al-Rubaye et al. (2015) identified the majority of BCO samples from 
the University of Arkansas Research Farm were Staphylococcus agnetis 908. The samples 
were isolated through broth enrichment from BCO lesions and direct plating on differential 
media. The isolated colonies were processed for PCR and sequencing of the 16S rRNA gene to 
identify to species. In contrast to the study by Jiang et al. (2015) which stated that the bacterial 
samples obtained from the femoral and tibial bones were different, this study detected S. 
agnetis isolates from all lesions regardless of the lesion type or location. Previously, this species 
had only been associated with cattle mastitis samples (Taponen et al., 2012, Shwani et al., 
2020). It was speculated that S. agnetis could be a contaminant present in commercial 
hatcheries possibly passed on by hatchery workers or equipment. Furthermore, administering a 
single dose of S. agnetis 908 in drinking water was able to induce BCO lameness in 50% of the 
chicken population, recognizing 908 as a highly virulent strain (Al-Rubaye et al., 2015).  
S. agnetis is a coagulase variable, Gram-positive bacteria that has been identified to induce 
lameness in broilers (Al-Rubaye et al., 2015). Phylogenomic analyses based on the 16S region 
identified that S. agnetis 908 is closest to isolates from cattle (Taponen et al., 2012) and 
microbiome samples from sheep mites (Hogg and Lehane, 1999). Staphylococcus hyicus and 
Staphylococcus chromogenes were the two closest species to S. agnetis based on neighbour 
joining tree results of 908 16s rRNA genes (Al-Rubaye et al., 2015).  
To further understand the relationship between the S. agnetis 908 chicken isolate and the 
cattle isolates, (Shwani et al., 2020) used whole genomes for elucidating the phylogenetic 
relationships of known S. agnetis isolates.  Although the cattle and chicken isolates were very 
similar the study did not conclusively identify acquisition or loss of any gene or gene cluster that 
coincided with the switch of hosts from cattle to chicken. Thus, it is hypothesized that 908 may 
possess alterations such as missense mutations in particular virulence factors that would 




surviving and escaping macrophages when compared to the closely related isolate from cattle, 
S. agnetis 1379 (Zaki, 2021). This had led to further investigations to identify and locate the 
virulence factors by employing Directed Genome Evolution (DGE).  
1.2. Deoxyribose phosphate aldolase 
To identify the virulence factors that allow 908 to survive and escape macrophages 
transformants of 1379 were created. S. agnetis 1379 was electroporated with whole genome or 
extrachromosomal ‘plasmid’ 908 DNA (Zaki, 2021; Shwani, 2021). The transformation product 
was passaged through chicken macrophage-like cells and after several rounds of selection the 
survivors were very similar to the 908 phenotype for survival and escape from macrophages. 
Multiple DGE products were produced, and their genomes sequenced, assembled, and 
compared to 908 and 1379. These analyses identified two alternative single nucleotide 
polymorphisms (SNPs) where either SNP could result in converting 1379 into a 908 phenotype 
for survival and escape from macrophage. The two alternative SNPs were each in one of two 
paralogs for deoxyribose aldolase phosphate (deoC or DERA). DERA which is a 220 amino acid 
polypeptide is coded by the paralogs deoC1 and deoC2 for both 1379 and 908. However, the 
major difference between 1379 from cattle, 1379 and 908 from chicken, was that in 1379 
residue 164 for both paralogs is alanine while in 908 both copies encode glutamate.  
DERA is an aldehyde-lyase that reversibly converts 2-deoxy-D-ribose 5-phosphate to D-
glyceraldehyde 3-phosphate and acetaldehyde. Acetaldehyde can then be converted to acetyl 
CoA and transferred to the glycolytic and Kreb’s cycle to generate energy (Lomax and 
Greenberg, 1968) . Salleron et al., (2014) revealed that an over expression of DERA in human 
cells allowed cells to survive by utilizing exogenous deoxyinosines to produce ATP in the 
absence of glucose and presence of an oxidative phosphorylation disrupter. Structurally, DERA 




aldolases which are generally involved in forming Schiff bases at Lys167 in the active site (Heine 
et al., 2004).  
  
Figure 2. Three-dimensional structure of 908 DERA generated using Cn3D software, NCBI. 
The A164E substitution is indicated in yellow located on the outer alpha helix of the 
homotetramer.  
 
1.3. Immune responses 
1.3.1. Macrophages 
Macrophages are the dominant effector cells of innate immunity but are also important in 
adaptive immunity found in organs and connective tissue (Abbas, Lichtman and Pillai, 2012). In 
blood circulation, they are identified as monocytes and once they transverse blood capillaries 
and enter tissues, termed as macrophages (Steinman and Cohn, 1974). Macrophages and 
monocytes arise from committed cells in the bone marrow that differentiate in response to the 
cytokine Monocyte-Macrophage Colony Stimulating Factor (M-CSF) (Abbas, Lichtman and 
Pillai, 2012). Many tissues have their own long-lived resident macrophages which are derived 




macrophage which have tissue-dependent specialized functions include: alveolar macrophages 
in the lungs (Joshi et al., 2018) and microglial cells  in the brain (Guillemin and Brew, 2004).  
  Macrophages are involved in innate immunity.  They can secrete cytokines such as TNF, 
several interleukins (IL-1, IL-10, IL-6), and chemokines, that are important for acute 
inflammatory response (Abbas, Litchman and Pillai, 2012). When stimulated by the cytokines 
and chemicals produced by T-lymphocytes, macrophages in large numbers are recruited to 
engage in adaptive immunity to eliminate pathogens (Fujiwara and Kobayashi, 2005). 
Figure 3. (A) The progression from a nascent, early phagosome to a phagolysosome. During 
the maturation process biochemical changes take place including the different markers 
displayed. (B) Laser scanning confocal micrograph images with Staphylococcus aureus (blue 
stained with eFluor670); (C-D) S. aureus in green (containing GFP). (Image reproduced from 
Flannagan et al., 2015)  
 
Macrophages populations are classified into two classes: M1- the classically activated, 
and M2- alternatively activated macrophages (Braga et al., 2015, Mills, 2012). M1 macrophages 
initiate inflammatory responses involved in eliminating pathogens while the M2 macrophages 




microbes and foreign antigens using receptors such as Toll-like receptor (TLR) on the cell-
membrane which identify Pathogen Associated Molecular Patterns (PAMPs) and Damage 
Associated Molecular Patterns (DAMPs) (Abbas, Lichtman and Pillai, 2012). In addition, they 
identify opsonized microbes. Once the pathogen is recognized, macrophages would engulf it 
through phagocytosis which encases the pathogen in a vacuole (Peterson et al., 1978). This 
nascent phagosome lacks microbicidal abilities until it matures to a late phagosome during 
which the pH within the vacuole is lowered by proton pumps to create an acidic environment 
toxic to pathogens (Figure 3). The mature phagosome then fuses with a lysosome to form 
phagolysosomes. The phagolysosomes contain reactive oxygen and nitrogen species, 
glycanases, lipases and proteolytic enzymes that are capable of destroying the microbe 
(Aderem and Underhill, 1999). Macrophage functions are not only limited to elimination of 
pathogens, but they are also involved in recognizing and engulfing dead host cells that have 
undergone necrosis or apoptosis. Macrophage can also stimulate T-cell mediated immunity 
through antigen presentation. Meanwhile, alternatively activated M2 macrophages are involved 
in tissue repair, angiogenesis, and fibrosis. Excessive activation of M2 macrophages has been 
identified to induce asthma and fibrosis (Moreira and Hogaboam, 2011).   
1.3.2. Bacterial evasion of phagocytosis 
Despite macrophage functioning as sentinels to prevent microbial infection and spread, 
several microorganisms have developed mechanisms to evade immune responses. Studies 
have revealed that Salmonella, Shigella and Yersinia are capable of secreting several Type III 
secretion components that span the bacterial cell-membrane (Kubori et al., 1998, Blocker et al., 
1999). This protein is involved in transporting certain chemicals to the extracellular space that 
could either promote bacterial uptake by host-cells which are not phagocytes (Galan and 
Collmer, 1999, Cornelis, 2000) or it could altogether prevent phagocytosis as displayed by 




Bacteria such as Staphylococcus aureus, Streptococcus pyogenes and Mycobacterium 
spp. are able to evade being recognized by the mannose binding receptors and Fc receptors on 
phagocytes.  Typically, these receptors would activate Cdc42 and Rac to initiate a cascade of 
reactions that would eventually eliminate the phagosome encased bacteria (Joiner et al., 1990, 
Lefkowitz et al., 1997). Instead, these bacteria subvert the process through binding to 
complement receptors that do not trigger microbicidal actions of the internalized bacteria 
(Yamamoto and Johnston, 1984). Other pathogens like Listeria, Rickettsia and Shigella are able 
to escape the phagosome utilizing pore-forming proteins across the phagosome membrane. 
They then enter the cytosol where they continue to replicate while evading destruction by the 
lysosome fusion (Gouin et al., 1999).   
Yet, another mechanism through which some pathogens evade immune responses is 
observed in Salmonella and Mycobacteria. Once internalized by a phagocyte, Salmonella 
secretes yet another Type III protein that blocks the lysosomal fusion with the phagosome 
(Uchiya et al., 1999). A similar observation was reported by (Kaufmann, 2005) in 
Mycobacterium tuberculosis where the bacilli produce a tryptophan-aspartate containing coat 
protein (TACO) which prevents the maturation and fusion of the phagosome with the lysosome 
(Ferrari et al., 1999, Armstrong and Hart, 1971). This mechanism is responsible for the long-
term survival of Mycobacteria within the alveolar macrophages.  
S. agnetis shares a significant number of virulence factors with S. aureus, a well-studied 
pathogen. S. agnetis chicken isolate 908 contains 17 recognizable virulence factors with 
potential to contribute to host immune evasion.  Among these are beta-toxins, toxin-A, a gene 
encoding for a putative hyaluronidase, five superantigen like proteins and seven fibronectin 





BCO is a debilitating bone infection which is an animal welfare issue that costs the 
broiler industry billions of dollars annually. Previous research had identified S. agnetis 908 as a 
virulent causative agent of BCO lameness in broilers. S. agnetis 908 is capable of surviving in 
and escape from macrophages when compared to a genetically similar cattle isolate. 
Understanding the mechanisms through which bacteria evade and survive immune responses is 
critical to development of management strategies to mitigate and control this disease.  
This study investigates the role of the deoC1 and deoC2 paralogs of S. agnetis 908 
which codes for DERA. Specifically, the work focused on identifying whether the A164E 
substitution is involved in increased bacterial survival and escape from macrophages. Chapter 2 
discusses the selection of transformants containing 908 DNA that display macrophage escape 
and survival through directed genome evolution, while Chapters 3 and 4 explore the effect of S. 
agnetis on the host-cells by utilizing gentamicin protection assays and enzyme protection 
assays paired with crystal violet staining for cell damage or death.  
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Macrophages are tissue-associated immune cells that are derived from the myeloid 
lineage (Murray and Wynn, 2011, Abbas, Lichtman and Pillai, 2012). They are important in both 
innate and adaptive immune responses and represent one of the first lines of defense against a 
pathogen invasion. Macrophages function by producing chemokines and cytokines that activate 
numerous immune cells. In addition, they trigger the complement cascade involved in pathogen 
lysis. However, the main function which macrophages are renowned for, is their ability to engulf 
pathogens and foreign antigens through the process termed phagocytosis (Drevets et al., 2015).  
Phagocytosis assays have been developed as a method to study the host interaction 
with microbes in vitro (Caponegro et al., 2021). These assays can be used to evaluate the 
ability of host immune cells to engulf and internalize a pathogen and determine the bactericidal 
capacity of the immune cell. For such purposes, the assay often uses fluorescence tagged 
bacteria or flowcytometry to enumerate the viable intracellular and extracellular bacterial counts. 
Furthermore, phagocytosis assays are used in determining the pathogen’s response to the host 
cell. Therefore, phagocytosis assays are a great tool to study host-pathogen interactions. The 
major components of a phagocytosis assay are the host cells, which could range from 
macrophages to polymorphonuclear neutrophils (PMNs), while the pathogen is most often a 
bacterial agent (Vonk et al., 2002) . 
In our study we use phagocytosis assays to understand the interaction between a 
chicken-macrophage-like cell line and the Gram-positive bacterium Staphylococcus agnetis.  
S. agnetis is a coagulase variable, Gram-positive bacterial species originally identified in 




recently been isolated from chicken diagnosed with bacterial chondronecrosis and osteomyelitis 
(BCO) (Al-Rubaye et al., 2015, Al-Rubaye et al., 2017). Our study mainly focuses on S. agnetis 
908, which had been isolated from BCO samples of chicken from the University of Arkansas 
Poultry Research Farm. Phylogenomics revealed that the chicken isolate 908 was most likely 
derived from within a clade of cattle isolates (Shwani et al., 2020). However, genomic changes 
attributed to the transition have yet to be established.  
Previously we have identified that S. agnetis 908 has the ability to survive and escape 
chicken and mouse macrophage-like cell lines (Zaki, 2021). In contrast the cattle isolate, S. 
agnetis 1379, is much more susceptible to these phagocytes, despite having a very similar 
genome (Shwani et al., 2020). To identify the genetic components that contribute to enhanced 
macrophage survival and escape, these two isolates were used for directed genome evolution 
(DGE). For our work, 1379 was transformed with 908 DNA and the transformants were 
passaged through multiple phagocytosis assays consisting of chicken-macrophage-like cells 
called HTCs. After several passages the survivors displayed the phenotype of isolate 908. 
Multiple independent DGE transformants were generated and subjected to whole genome 
sequencing and genome assemblies were compared to 908 and 1379.  This led to the 
identification of specific substitutions in either of two paralogs for deoxyribose-phosphate 
aldolase (deoC).  
Both paralogs of the deoC gene code for a 220 amino acid polypeptide and both are 
located upstream of a gene coding for phosphopentomutase. The two paralogs can be 
distinguished by the other flanking genes. The gene upstream of deoC1 is ATP 
phosphoribosyltransferase regulatory subunit (hisZ) which is transcribed in the opposite 
direction as deoC1. The gene upstream of deoC2 is tetracycline resistance MFS efflux pump 
(TRI12) which is transcribed in the same direction as deoC2. Results of tBlastn searches 




similar to 908 deoC2. Furthermore, the major difference between the two paralogs in 908 vs 
1379 is that residue 164 is an alanine in S. agnetis 1379, while it is a glutamate for 908.  
2.1.1. Directed Genome Evolution 
Directed Genome Evolution (DGE) mimics the evolutionary process of selection in a 
controlled, laboratory setting. Organisms are selected for a desired trait after subjecting the 
organisms to repetitive rounds of selection processes (Cobb et al., 2013). It has been used as a 
method to screen for virulence determinants in organisms that are genetically similar but have 
different phenotypes, as  DGE was used to identify the specific amino acid substitution in a 
porin gene in Campylobacter jenuni associated with spontaneous abortion in sheep (Wu et al., 
2016). 
Previous research in our laboratory had utilized DGE to select for transformants of 1379 
that display the phenotype of 908 for escape from and/or survival of HTCs during multiple 
rounds of phagocytosis assay (Zaki, 2021). This led to the identification of the deoC genes as 
the most likely determinant for this phenotype. In this chapter we used DGE to select for 
transformants of 1379 using specific PCR fragments containing the 908 deoC1 or deoC2.   
2.2. Materials and methods 
2.2.1. Cell cultures 
Chicken-macrophage-like cell line (HTCs) was provided by Dr. N. Rath (Poultry Science 
Center, University of Arkansas, Fayetteville, AR) (Rath et al., 2003). The cell-line was 
maintained in cell culture flasks incubated at 37oC and 5% CO2 and passaged in 1:10 ratio 
every five days. The growth media used contained RPMI-1640 (Corning, Manassas, VA), 
supplemented with 1 x concentration of antibiotic–antimycotic solution (Invitrogen, Waltham, 
MA), 10 µg/mL of gentamicin sulphate (VWR, Radnor, PA), 1 mM sodium pyruvate (Invitrogen, 




low endotoxin fetal bovine serum (FBS) (Gibco, USA) (Rath et al., 2003) The volumes are 
described in protocol 1 (Supplementary).   
The same medium was used in phagocytosis assays except the antibiotic- antimycotic 
solution and gentamicin was omitted and is referred to as antibiotic-free growth media. 
Gentamicin growth medium contained 50 µg/mL of gentamicin but did not contain the antibiotic-
antimycotic solution.  
2.2.2. Bacterial strains 
The two main bacterial strains used in this study were S. agnetis 908 and 1379. S. 
agnetis 908 was obtained from chicken BCO samples from the University of Arkansas Poultry 
Research Farms. S. agnetis 1379 (MU50.56) was isolated from subclinical mastitis samples 
provided by Dr. J. Middleton from Department of Veterinary Medicine and Surgery, University of 
Missouri. The bacterial strains were maintained on Tryptic Soy (TS) agar slant at 4oC.  
Figure 4. DNA sequence of the region of the S. agnetis deoC1 gene with the location of the 
PCR primers used to amplify specific regions.  
Previous work involved transforming 1379 with whole genomic and extrachromosomal 




PCR products. The primer pair 908alS1F x 908ald1R2 partially covered the last half of the 
upstream gene phosphopentomutase to most of the deoxyribose phosphate aldolase gene 
(spanning 724 nucleotide bases including the codon that codes for the amino acid residue 164) 
(Figure 4).   
Transformation was performed using electroporation (Shwani, 2021). The transformation 
with 908 deoC1 was divided into four biological replicates designated 1589A through 1589D. 
Similarly, the transformation with 908 deoC2 generated DGE products 1590A through 1590D. 
All stock samples were stored in -80o C in TS broth containing 40% glycerol.  
2.2.3. Phagocytosis Assay to determine the effect of multiplicity of infection. 
A day prior to the assay, the cell cultures were incubated in antibiotic free growth media 
overnight. The media was aspirated and prewarmed 1 x Phosphate Buffered Saline (PBS) was 
added to the cell culture flask. The cells were scraped with a cell scraper and transferred into a 
15 mL centrifuge tube. The cells were sedimented by centrifugation at 400 x G for 5 minutes. 
The pellet was resuspended in antibiotic free growth medium. Countess automatic cell counter 
(Invitrogen Waltham, MA) was used to enumerate the HTCs in 10 µl of the HTC suspension 
mixed with 10 µl of Trypan Blue. The HTC suspension was then diluted to achieve a 
concentration of 3 x 105 cell/mL of which 0.5 mL was added to each well of a 24-well tissue 
culture plate. 
Overnight (2 mL, 37oC, shaking at 120 RPM) TS broth cultures of S. agnetis 908 or 1379 
were diluted 1:100 in antibiotic free RPMI media and their optical densities were measured at 
650nm. The Colony Forming Units (CFU) per ml were estimated using standard curves for 908 
and 1379 (Supplementary figure 21). The bacterial suspensions were diluted in antibiotic-free 
medium to achieve a concentration of 3 x 105 CFU/mL.   
The cocultures were incubated at 37oC, 5% CO2 for four hours to allow for phagocytosis 




Phagocytosis was stopped by placing the tissue culture plate on ice for 10 minutes. The wells 
were then washed twice with 0.5 mL of ice-cold PBS to remove non-adherent cells and replaced 
with gentamicin growth media and incubated overnight (16 to 18 hours) at 37oC, 5% CO2. The 
following day, growth media was removed, and the wells were washed twice with 1 x PBS and 
replaced with 0.5 mL of antibiotic-free growth media. The plate was once again incubated 
overnight at 37oC, 5% CO2. Following the overnight incubation, based on phase contrast 
microscopy observations of the number of extracellular bacteria in the well, estimates were 
made to determine the dilution factor. The media in the wells were then transferred into 1.5 mL 
microcentrifuge tubes. This is referred to as the ‘supernatant’ which refers to the bacteria 
present outside the HTCs. The remaining HTCs in the wells were lysed by adding 0.5 mL of 
sterile distilled water and referred to as the ‘lysate’ which constitutes the cell-associated and 
bacteria internalized by HTCs. Serial dilutions of the supernatant and lysate were performed 
using TS broth and 100 µl of the final dilution was plated on TS agar plates which were 
incubated overnight at 37oC for colony counts. 
2.2.4. The effect of various types of sera on bacterial survival 
The phagocytosis assay was carried out as described above. The growth media used in 
the assay, including antibiotic free growth media and growth media supplemented with 
gentamicin, were prepared as described in the previous section with the exception of the serum 
used. Instead of 10% low-endotoxin FBS, growth media was supplemented with 10% high-
endotoxin FBS, chicken serum and BCO plasma for each of the respective categories tested. 
Table 1 describes the composition of each type of serum. 
Both S. agnetis 908 and 1379 were tested for their ability to survive macrophages in 
each of the four types of growth media. All samples were in triplicates. Two days after coculture 
the total number of viable bacteria (Both extracellular and intracellular) were enumerated by 




Table 1. Different sera used in the experiment and their constituents. 
Type of serum / plasma Components 
Low-endotoxin Fetal Bovine 
Serum 
Fetal Bovine Serum filtered with triple 0.1 µm filtered 
(Gibco) 
High-endotoxin Fetal Bovine 
Serum 
Fetal Bovine Serum, non-certified for endotoxin 
(Gibco) 
Chicken serum Chicken serum. Source: New Zealand (Gibco) 
BCO plasma Plasma separated from blood from broilers at the 
University of Arkansas Research Farms infected with 
BCO 
2.2.5. Directed Genome Evolution 
 The selection process for DGE used in our study is macrophage survival through 
multiple rounds of phagocytosis assays.  This was used in screening for the transformants 
(1589A to D and 1590A to D) that display 908’s phenotype of macrophage survival. S. agnetis 
908 and 1379 were used as controls. Phagocytosis assay was carried out as described in 
section 2.2.3. Two days after coculture, the supernatant and lysate were plated on TS agar and 
incubated overnight at 37oC.  
2.2.6. Molecular analysis 
Colony Screening by PCR Sequencing 
 Individual colonies were picked and transferred on to a master TS agar plate. The plate 
was incubated overnight at 37oC. The master place streak was sampled with a sterile toothpick 
and suspended in 100 µl of sterile distilled water in 0.2 mL microcentrifuge tubes. The tubes 
were thoroughly mixed by vortex and heated to 100oC for 10 minutes followed by 20oC for 10 
seconds and stored at 4oC until use. 
DNA from colonies was verified by amplification using qPCR-HRM (quantitative PCR 
High Resolution Melt) with the 16SV2 primers: Bac16Sv2 F 5′-




(Zaki, 2021). The PCR mixture contained the following: 2µl of 10X buffer, 0.2 µl of 20 mM 
dNTPs, 0.2 µl of 10 U/ µl Taq Polymerase, 1 µl of 20 µM forward and reverse primers and 2 µl 
of the template DNA from the colony boil samples, in a total volume of 20 µl.  S. agnetis 908 (2 
ng/ µl) and 1379 (2 ng/µl) of DNA were used as positive controls while a reaction tube with no 
template DNA was used as the negative control. The samples were subjected to the following 
PCR conditions: Initial denaturation of 90oC for 30 seconds, followed by 30 cycles of 
denaturation at 90oC for 15 seconds, annealing temperature at 60oC for 30 seconds, and 
elongation at 72oC for 90 seconds, followed by the final elongation at 72oC for 180 seconds.  
 Following the PCR reaction, amplification was evaluated by electrophoresis in a 1.5% 
agarose gel. TyphoonTM FLA 9500 (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) was 
used to scan ethidium bromide-stained gels.  
 The PCR samples with positive 16S bands were then subjected to PCR with 
908alS1Fx908ald1R2 primers. The reaction mixture was prepared as described above. The 
PCR conditions were as above except the anneal temperature was 59oC. 
The PCR products were quantified by using Hoecht staining and fluorimetry with a 
GloMax Jr according to manufacturer procedures (Promega, Madison, WI) The quantified PCR 
samples were then cleaned using RapidTips (Chiral Technologies, West Chester, PA). The 
908ald1R2 primer was added to the cleaned PCR products and submitted for capillary 
sequencing by the Eurofins Genomics Company (Louisville, KY).  Sequence data was analyzed 
using SeqMan Pro software (DNAStar version 16, Madison, WI). S. agnetis 1379 genome was 
used as the reference genome (Shwani et al. 2020).  
2.2.7. Statistical analysis  
Student t-test and one way ANOVA followed by Tukey’s post hoc test were used in 
statistical analysis. All analyses were done using R (R Core Team, 2019) and Microsoft Excel. 





2.3.1. Multiplicity of infection  
 
Figure 5. The bacterial counts in Colony Forming Units (CFU/mL) obtained from plating the 
supernatant (solid fill) and lysate (hatched fill) two days after coculture. S. agnetis 1379 in blue, 
908 in orange. The error bars represent standard deviations (n=3).  
 
To compare the effect of varying concentrations of bacteria on HTCs, bacteria of 
concentration 3 x 105 cells/mL were added to each well with 0.5 mL of HTC in volumes 
described in table 2. All samples were run in triplicate.  
Table 2. Indicates the volumes of each bacterial suspension of concentration 3 x 105 cells/mL 
that was added to each well. 
 Ratio 1     2:1 4:1 
Volume of Bacterial suspension (mL) 0.5 0.25 0.125 
Volume of HTC (mL) 0.5 0.5 0.5 
 
 Reducing the concentration of bacteria did not have a significant effect in bacterial 
survival in both the supernatant and lysate groups (P > 0.05). Overall, S. agnetis 908 had 

































the lysate, and extracellularly as reflected by the bacterial counts of the supernatant (Figure 5). 
No bacterial growth was observed when 1379 was cocultured with HTCs in 2:1 ratio.  
2.3.2. The effect of various types of sera on bacterial survival 
 
Figure 6. The effect of sera on bacterial survival of S. agnetis 908 (hatched fill) and S. agnetis 
1379 (solid fill). The survivors consist of combined total of the intracellular and extracellular 
bacterial populations and is measured in log transformed colony forming units (CFU)/mL. Error 
bars represent standard deviations (n=3) 
 
To test for the effect of different sera used in supplementing the growth media we tested 
the survival response of S. agnetis 908 and 1379 to growth media enriched with four different 
types of sera: High-endotoxin FBS, low-endotoxin FBS, chicken serum and BCO plasma. BCO 
plasma was obtained from separating plasma from blood drawn from broilers at the University of 
Arkansas Research Farm diagnosed with BCO.  
The number of viable S. agnetis 908 and 1379 significantly decreased when growth 
media supplemented with plasma from chicken infected with BCO (P < 0.05). Meanwhile using 
high-endotoxin serum or chicken serum did not have profound effects on bacterial survival 
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endotoxin FBS and chicken serum were used. However, 908 showed higher macrophage 
survival (4.48x1010 CFU/mL) when incubated with high-endotoxin FBS (P = 0.013). 
2.3.4. Directed Genome Evolution 
Figure 7. The survivors (both extracellular and intracellular) of the first round of DGE indicated 
by CFU/mL. The colony counts are log transformed. Error bars represent standard deviations 
(n=3). 
DGE was used to positively select for the transformants that displayed macrophage 
survival and escape similar to 908.  This screening process utilized phagocytosis assays where 
the transformants were cocultures with HTCs. S. agnetis 1379 has the lowest colony counts 
indicating the least number of survivors with only 6x105 CFU/mL (Figure 7). In contrast S. 
agnetis 908 had colony counts of 8.8x1010 CFU/mL.  The first round of DGE identified 1589A, 
1589B and 1589C which were transformed with 908 deoC1 to have significantly higher survivors 
compared to 1379 (P < 0.05) while the transformants of 908 deoC2 did not show significant 
survival (P > 0.05). Transformant 1589A had the highest number of colony counts (8.05x108 
CFU/mL) from all 1589 transformants. Some of these colonies may have incorporated the 908 




Due to lack of reproducibility, the second round of phagocytosis assay was not 
completed (Described in section 2.4.3).  
2.3.5. Molecular analysis 
Since the 1589A, B and C transformants displayed phenotypes closest to 908, individual 
colonies were subjected to DNA sequencing to determine their genetic composition. Following 
the first round of DGE, PCR was carried out on the surviving 1589A, 1589B and 1589C colonies 













Figure 8. (A) Gel images for PCR with 16SV2 primers. (B) Bands from PCR with 
908alS1Fx908ald1R2 primers. 
 Figure 8 shows the results for the PCR reaction with the initial 16SV2 primers that 
positively identified and confirmed the presence of bacterial DNA. Following which, those 
samples were subjected to PCR using the 908alS1Fx908ald1R2 primers. The results show 
weak bands for two of the 1589A replicates and 1589B replicates and a single replicate for 






































































































































Four of the five samples sent for sequencing – 1589A1, 1589A3, 1589B2 and 1589C1 provided 
results of good quality. Aligning these sequences with S. agnetis 1379 as the reference gene, 
we identified that bases corresponding with positions 2,765 to 2,850 were different for the 
transformants relative to 1379 but were identical to 908. However, from 2,660 and 2,621 bases, 
the transformants had sequences unique to them.  
Figure 9. SeqmanPro alignment of the PCR sequence data for DGE transformants aligned with 
1379 and 908 reference sequences. Region spans the codon for residue 164 (blue highlight).  
 
Furthermore, bases 2,846 to 2,848 which codes for the 164th amino acid residue was 
GAA for all transformants which was identical to that of 908. GAA codes for glutamate. 
Meanwhile the same bases in the reference 1379 gene were GCA which codes for alanine. 
Thus, it is evident that the transformants that survived macrophages in a manner similar to that 
of 908 possess the A164E substitution. In addition, the results are indicative of a successful 




2.3.6. Problems with phagocytosis assays 
Figure 10. (A) Survivors of round-1 of DGE. S. agnetis 908 has the highest number of survivors 
followed by transformants 1589A, 1589D, and all of 1590A-D and 1379 with the least number of 
survivors. (B) Round-2 of DGE, with 908 having the highest number of survivors. Only 1589A, 
1589B, 1590A and 1590D displayed the survival phenotype. 1589D and 1590C did not contain 
viable bacteria in supernatant. Supernatant in solid fill, lysate indicated by the hatched fill.  
Phagocytosis assays were carried out to study the interaction between S. agnetis and 
the HTCs. Enumerating the total viable bacteria after cocultures provides understanding on the 
virulence of the bacterial strain. The phagocytosis assay results proved difficult to reproduce. 
















































control did not display consistent results in terms of survival. The first round of phagocytosis 
assay (Figure 10.A), 1379 had a total of 2.28x107 CFU/mL of bacteria surviving macrophages, 
but only 2.5x103 CFU/mL were isolated from the supernatant. However, when the experiment 
was repeated by passaging the survivors of round one, 1x108 CFU/mL of 1379 were isolated 
from the supernatant (Figure 10.B). Yet, the total number of viable 1379 remained constant 
between 2x107 to 2x108 CFU/mL.  
Additionally, the survivors for transformant 1589B and C were less than that of 1379 in 
the first round of DGE. Furthermore, transformants 1589D and 1590C did not have viable 
bacteria in the supernatant but when lysate was plated, 1589D had 3.6x103 CFU/mL and 1590C 
had 3.1x104 CFU/mL of viable bacteria.  
2.4. Discussion 
2.4.1. Comparison of different multiplicity of infection. 
Multiplicity of infection (MOI) is defined as the ratio of infective agents to the target, 
which in our study is the ratio of S. agnetis 908 or 1379 to HTCs (Abedon and Bartom, 2013). 
Our findings indicate the MOI did not influence the outcome of the phagocytosis assay. The 
HTCs did not have an advantage when the concentration of bacteria was decreased nor were 
the bacteria more susceptible to elimination. Others (Hamza and Li, 2014) have reported similar 
results where the MOI did not have an effect on the number of viable intracellular 
Staphylococcus aureus and cytolysis. Instead, that study reported that the infection time 
influenced the number of bacteria internalized by macrophages.  However, organisms where the 
MOI influence the immune reaction and cytolysis do exist. Mycobacterium tuberculosis is one 
such bacteria. Several studies describe that increasing the MOI enhances apoptosis of 
macrophages and ability of the immune cells to eliminate the bacilli, but these findings were not 




We did not observe viable bacteria when HTCs were cocultured with S. agnetis 1379 in 
a 2:1 ratio. It is possible that this might have been a result of erroneous pipetting leading to 
inaccurate bacterial or HTC concentrations.  
2.4.2. The effect of various types of sera on bacterial survival 
 Our results indicated that using plasma from chicken diagnosed with BCO drastically 
decreased the number of both S. agnetis 908 and 1379 alike. Plasma, unlike serum, contains 
clotting factors and apart from differences in electrolyte and chemical composition, both plasma 
and serum contain immunoglobulins (antibodies) and proteins such as albumin and complement 
factors (Triglia and Linscott, 1980, Hrubec et al., 2002). The plasma from BCO chickens likely 
contains antibodies against BCO causing pathogens such as S. agnetis. Several studies have 
identified that opsonization of the pathogen by the antibodies result in an increase in the rate of 
pathogen elimination. Furthermore, it enhances macrophage oxidative bursts (Cheng et al., 
2001).  Antibodies against fibrinogen binding protein of Staphylococcus epidermidis were more 
efficient at opsonization of this bacterium resulting in more potent phagocytosis, compared to 
antibodies against autolysin E (Rennermalm et al., 2004). However, a study on Group B 
Streptococci revealed that the antibodies were able to kill bacteria regardless of the type of 
serovar (Cheng et al., 2001). At present we do not have data on the type of antibodies present 
in BCO plasma, but it is consistent with other studies, that the presence of antibodies in plasma 
or serum would kill pathogens efficiently as reflected by the low bacterial counts for both 908 
and 1379.  
 Our routine growth media are supplemented with 10% low endotoxin fetal bovine serum 
(FBS). Endotoxin consists of lipopolysaccharides (LPS) and (1→3)-beta-D-glucan (Nikaido and 
Vaara, 1985). When present in serum used in supplementing cell or tissue culture growth 
media, it affects the bioactivity of the cell lines which then impacts the outcome of experiments.  




media/serum. The presence of endotoxins in cell cultures stimulates the production of Tissue 
Necrosis Factor (TNF) (Rietschel et al., 1994). TNF production in J774.1 cell line induced by 
LPS occurs in a dose-dependent manner (Kirikae et al., 1997). Our findings report a significant 
difference between the number of survivors of 908 and 1379 when growth media supplemented 
with high-endotoxin FBS is used. However, there is no significant difference between 1379 
survivors when incubated with low endotoxin and high endotoxin growth media which suggests 
that the outcomes are not exclusively the result of the type of serum used. Additionally, there 
appears to be an overall large number of 1379 survivors regardless of the type of sera used with 
the exception of BCO plasma. This further proves that the outcome observed is not solely based 
on the serum used.  
2.4.3. Directed Genome Evolution and phagocytosis assays. 
 DGE requires multiple rounds of phagocytosis assays to select for the transformants 
with the macrophage survival phenotype of 908. The first round of phagocytosis assay identified 
three biological replicates of 1589 which were transformed with 908 deoC1 gene that showed 
macrophage survival closer to 908, but not identical. To ensure the accurate phenotype, the 
survivors should be passed through HTCs once again. However, the lack of reproducible results 
confounded the second round of phagocytosis assay.  
There are several factors that could contribute to these inconsistent results. We 
hypothesized that the overnight incubation in 50 µg/mL of gentamicin could have contributed to 
the inconsistencies. This step is carried out to ensure that all extracellular bacteria are 
eliminated so that the internalization of bacteria are kept constant by limiting phagocytosis to 
only four hours. In addition, gentamicin, an aminoglycoside, is supposedly impermeable to 
eukaryotic cells, therefore it would exclusively eliminate the extracellular bacteria. However, it 
should be noted that it is important to test for antibiotic susceptibility of bacteria to gentamicin 




high concentration of gentamicin may have allowed gentamicin to enter the eukaryotic HTCs 
(VanCleave et al., 2017, Drevets et al., 1994, Ohya et al., 1998, Eze et al., 2000, Hamrick et al., 
2003). Internalized gentamicin paired with the possibility of differential sensitivity of 908 and 
1379 to gentamicin may have influenced the results of the phagocytosis assay. This is 
investigated further in chapter three.  
Despite the confounding issues with the phagocytosis assay, we were able to select and 
sequence the DGE survivors for the first round of phagocytosis. The results indicate that 85 
nucleotide bases of the transformants with phenotype close to that of 908 macrophage survivors 
contained the 908 sequence for codon 164 of deoxyribose aldolase phosphate gene. Previous 
DGE research had identified that the only consistently transferred change in 1379 when 
transformed with 908 DNA and selected through HTC phagocytosis assays was the substitution 
of the polar amino acid glutamate for the non-polar alanine for amino acid 164 of deoxyribose 
phosphate aldolase. When 1379 was transformed with 908 whole genome DNA, the survivors of 
DGE were sequenced and revealed to have the A164E substitution.  This suggested that the 
A164E substitution had a role in influencing 908’s ability to survive or escape macrophages. The 
importance of the 1589 transformants with the PCR products of 908 deoC1 gene are that the 
survivors all contain the 908 codon for residue 164.  This confirms the function of deoC in 
macrophage survival. Whereas the previous DGE transformants with 908 DNA contained 
multiple sequences from the 908 donor DNA (Shwani, 2021). Therefore, the current findings not 
only confirm a successful transformation but also proves that the A164E substitution is 
associated with the survival in and escape from macrophages.  
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Gentamicin Protection Assays 
3.1. Introduction 
Gentamicin Protection Assays (GPA) can be used to evaluate the number of viable 
bacteria with in a host cell. Gentamicin is an aminoglycoside with bactericidal effects. It has 
been the drug of choice for treating aerobic Gram-negative bacterial infections espcially those 
that are caused by the Enterobacteriaceae family (Chaves and Tadi, 2021). 
Gentamicin requires oxygen to cross the Gram-negative bacterial cell membrane. Once 
inside the cell, it binds to 16S rRNA at the 30S ribosomal unit (Beganovic et al., 2018). This 
inhibits translation of mRNA resulting in the production of non-functional, faulty proteins, which 
are thought to be responsible for cell wall impermeabiltiy. In addition gentamicin would increase 
the production of reactive oxygen species. It is hypothesized that the combinatory effect of a 
permeable cell wall and reactive oxygen species results in bacterial cell death (Kohanski et al., 
2007). 
Gentamicin has been known for its poor membrane permeability thereby, lacks the 
ability  to enter eukaryotic cells. Due to this property, it has been the basis for antibiotic 
protection assays and has been widely used in studies to eliminate  extracellular bacteria 
(VanCleave et al., 2017). 
GPA has been used to study the invasiveness of bacteria such as Shigella by exposing 
the infected host cells to gentamicin for a short period of time (Sharma and Puhar, 2019). It has 
also been used in studies which ennumerate the internalized bacteria using techniques such as 
fluorescence microscopy-based, immunofluorescence and FACSflourescence imaging.  In our 




exracellular bacteria which was important in order to study the effect of intracellular bacteria on 
macrophages.  
Despite the wide use of antibiotic protection assays, several studies reveal that 
gentamicin is capable of slowly entering the eukaryotic cell over time and hence influencing the 
number of intracellular bacteria (VanCleave et al., 2017, Drevets et al., 1994, Ohya et al., 1998, 
Eze et al., 2000, Hamrick et al., 2003). These studies have highlighted the importance of 
evaluating the optimal time and concentration for gentamicin exposure. 
3.1.1. Crystal violet assay to study the effect of S. agnetis on HTCs. 
The Directed Genome Evolution (DGE) experiment posed a few problems. Obtaining 
consistent results were a challenge. Microscopic observations suggested that the HTCs had 
significant damage the day following the coculture. To study the damage inflicted by each 
bacterial strain and the 1379 transformant, a staining technique using crystal violet dye was 
used. 
Crystal violet stains the adherent cells by binding to the cell proteins and DNA. Non-
viable HTCs and bacteria will detach from the plate surface and are removed. Subsequent 
staining with crystal violet would indicate only viable cells (Feoktistova et al., 2016). To 
obeserve the affect of bacterial invasion on the host cells, we used crystal violet to stain viable 
macrophages. Gentamicin Protection Assay was used to ensure bacteria that escape 
macrophages would not proliferate extracellularly. 
3.1.2. Determining bacterial survival within macrophages  
Macrophages are the first line of defense during an infection. Once the bacteria has 
been engulfed by the macrophage, they are encased with in phagosomes where they are killed 
with in 15 to 30 minutes by host defense mechanisms such as reactive oxygen species, acidic 




Despite being a hostile environment, macrophages are known to be the preferred replication 
site by most pathogenic bacteria (Thi et al., 2012, Price and Vance, 2014).  
Bacteria are constantly evolving to be able to use the host intracellular environment to 
their benefit. They are capable of altering gene expression to allow for survival and proliferation 
with in the host (Mekalanos, 1992).  For example, Yersinia pestis is able to evade phagocytosis, 
while Listeria and Shigella species are able to escape phagosomes and enter the cytosol 
(PizarroCerda et al., 1997).  Other bacteria like Legionella species and Mycobacterium 
tuberculosis and Salmonella are able to prevent the fusion of lysosome and the phagosome and 
prevent acidification of the phagosome respectively.  
To better understand the extent to which S. agnetis  908 and 1379  would survive within 
the HTCs, we lysed the remaining HTCs on day 0, day 1, day 2 and day 3 to determine the 
number of cell-associated bacteria.  
3.1.3. Comparing the effect of heat-inactivated serum on HTC viability  
Heat inactivation of serum eliminates complement proteins that are involved in eliciting 
immune responses in the host. This is important in cytotoxity assays and viral assays where the 
presence of complement proteins would interfere with results. Several studies highlight the 
importance of heat inactivating serum. (Fante et al., 2021) states that heat inactivation of human 
serum promotes human T cell function by reducing  C1 inhibitor levels, C3c, C4 and factor B 
levels while enhancing C1q-IgG and Csd-IgG leves. Heat-inactivated serum has also been 
recommended for growing embryonic stem cells lines (Robertson, 1987) and for insect cell lines 
(Weiss et al., 1992). Soltis et al., (1979) states that heat inactivation of serum helps avoiding 
immunoglobin aggregation.  In addition, in the past it had served as a method to eliminate 
mycoplasma and other microorganisms which are known cell culture contaminants. However, at 
present filteration through 0.1 µm filters eliminate mycoplasma thus heat inactivation is not 




Fetal bovine serum (FBS) is a common component in cell cultures, serving as a nutrient 
source and enhances cell proliferation adherence to surfaces. FBS is composed of several 
complement proteins including 1-3% of human complement levels of C1 and C6 and 5-50% of 
human levels of other complement proteins with the exception of C3 (Triglia and Linscott, 1980). 
FBS is completely devoid of fibrin and clotting factors while bovine serum albumin is one of the 
major consituents of FBS. Other components include growth factors such as hormones, lipids, 
sugars and protease inhibitors which supports cell growth and provides protection to the cells 
(Shah, 1999, Even et al., 2006, Kawakami et al., 2016).  
Whether serum should or should not be heat-inactivated has been a debate in the 
scientific community. As of recent, heat inactivation of serum has been discouraged since 
exposing serum to heat not only destroys heat labile complement proteins but also tend to 
reduce or destroy serum growth factors essential for cell proliferation and adhesion(Giard, 
1987). In their study, Soltis et al., (1979) also reveals that heat inactivation had negatively 
impacted the growth and proliferation of six cell lines (HBAE, MDBK, Vero, human foreskin 
fibroblast, MRC-5, and Mv 1Lu).  
Therefore, to study the affects and implications of using heat-inactivated serum in our 
cocultures we compared the number of viable HTCs following the infection with S. agnetis  908 
and 1379 in media supplemented with normal fetal bovine serum (NS) and heat-inactivated FBS 
(HI).  
3.2. Materials and methods 
3.2.1. Determining Staphylococcus agnetis sensitivity to gentamicin  
A 1/100 dilution of an overnight bacterial suspension of 1379 and 908 was made by 




varying concentration of gentamicin sulphate solutions ranging from 5 µg/mL to 100 µg/mL were 
prepared as described in the table 3. 
Table 3. Volumes of gentamicin sulphate solution added to create a series of varying 
concentrations to test for sensitivity of S. agnetis 908 and 1379 to gentamicin. 
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The samples were incubated at 37oC. Optical density readings at 650 nm were taken at each 
hour for 5 hours. The respective CFU counts were obtained by using the standard curve for 
each bacterium (Supplementary figure 21).  
3.2.2. Crystal violet assay 
Preparing the coculture 
Bacteria were coculutred with HTCs in 1:1 ratio. Briefly, after an overnight incubation in 
RPMI 1640 growth media with no antibiotics or antimycotics, HTC cells were scraped and 
aspirated into a 15 mL conical flask. The HTC cells were sedimented by subjecting to 
centrifugation at 400xg for 5 minutes. The HTC pellet was resuspended in growth media with no 
antibiotics or antimycotics. The cell count was obtained using The CountessTM automated cell 




suspension containing 2x105 cells/mL of HTC cells was prepared and 0.5 mL was added into 
each well of a 24 well tissue culture plate. 
Overnight subcultures of S. agnetis  908 and 1379 was diluted 1:100 in RPMI 1640 
growth media with no antibiotics or antimycotics. The optical density was measured at 650 nm. 
The colony counts were for each dilution was determined using the standard curves 
(Supplementary figure 21). A dilution was made to achieve 2x105 cell/mL and 0.5 mL of this 
suspension was added to each well containing 0.5 mL of 2x105 cell/mL of HTC.  
The coculture was incubated at 36o C, 5% CO2 for 4 hours to allow for phagocytosis to 
take place after which the plate was placed on ice for 10 minutes to stop phagocytosis. The 
wells were washed twice with 1 x Phosphate Buffered Saline (PBS) to remove any extracellular 
unattached bacteria or HTCs.  
Crystal violet staining 
The wells were stained with 0.5% crystal violet on day 0 (Following 4 hours of 
phagocytosis), day 1, day 2 and day 3 following coculture. For wells allocated for days 1 to 3, 
the wells were refed with 0.5 mL of RPMI 1640 with 50 µg/mL of gentamicin following the wash 
with PBS.  
Crystal violet assay was performed as described in (Feoktistova et al., 2016) with slight 
modifications. In brief, 200 µl of 0.5% Crystal Violet was added to the PBS washed wells and 
allowed to incubate for 20 minutes at room temperature on a bench rocker with a frequency of 
20 oscillations per minute (University of Kansas Medical Center, 2021). Crystal violet was then 
removed, and the wells were washed four times with distilled water ensuring that cell are not 
washed away. The plate was then allowed to dry for four hours. The stain was solubilized by 
adding 600 µl of methanol and incubating the plate for 20 minutes at room temperature on a 
bench rocker with a frequency of 20 oscillations per minute.  Two-hundred 200 µl of methanol 
solubilized crystal violet stain was transferred on to a 96 well flat bottom microtiter plate and 




Winooski, Vermont) at 570 nm. Each sample was run in triplicate and three empty wells stained 
with crystal violet was used as the blank. 
3.2.3. Determining bacterial survival within macrophages  
Bacteria and HTCs were cocultured as described in the above section. The gentamicin 
protection assay was carried out over a three day period during which each day, the wells were 
replaced with 0.5 mL of RPMI 1640 growth media supplemented with 50 µg/mL of gentamicin 
and allowed to incubate overnight with the exception of wells allocated for day 0. These wells 
were subjected to only a two-hour incubation with gentamicin supplemented growth media and 
then lysed to determine the cell associated bacterial counts. The only variation was the 
introduction of 1589A which is a DGE transformant of S. agnetis 1379 (Described in Chapter 2).  
The wells to be processed were washed with 1 x PBS four times and 0.5 µl of sterile 
distilled water was added in order rupture the remaining HTCs. The lysate was aspirated into a 
1.5 mL microcentrifuge tube. 1/10th dilution of the lysate was plated on Tryptic Soy (TS) agar 
plates and incubated overnight in 37oC. This would provide the cell-associated bacteria for each 
day.  
3.2.4. Comparing the effect of heat-inactivated serum on HTC viability  
The coculture and gentamicin protection assay was performed as described in the 
previous section. For the heat-inactivated group, RPMI 1640 growth media was enriched with 
heat-inactivated  fetal bovine serum (FBS). In brief, heat-inactivated FBS was prepared by 
incubating low-endotoxin FBS (Gibco) at 56oC for 30 minutes, shaking every 10 minutes 
(Johnson, 2012, ATCC - Purpose of heat-inactivating serum-154, 2021). Heat-inactivated FBS 
was added to growth media containing sodium pyruvate (Invitrogen, Waltham, MA), 2-
mercaptoethanol (Invitrogen, Waltham, MA), L-GlutaMAXTM (Invitrogen, Waltham, MA) and 




up to 10% of the total volume of media. Growth media enriched with normal FBS was also 
prepared in a similar manner. Each sample was run in triplicates.  
Crystal violet assay was performed on each day, for three days following the coculure as 
described in the previous section. Sampling was done on day 0 (4 hours after coculture), day 1, 
day 2 and day 3. 0.5 mL of growth media containing 50 µg/mL of gentamicin was added to each 
well each day. The optical density at 570 nm was measured using the microtitre plate reader.  
3.3. Results 
3.3.1. Results of Staphylococcus agnetis sensitivity to gentamicin 
The OD and CFU data indicate that 908 is susceptible to all concentrations of 
gentamicin sulphate after 2 hours of incubation (Figure11). However, 1379 does not appear to 
be affected by gentamicin sulphate (Figure 12). Interestingly, all gentamicin sulphate treated 
samples are similar to the untreated control 1379. 
Figure 11. Computed colony forming units of S. agnetis 908 following treatments with different 
concentrations of gentamicin sulphate over a 5-hour period. The control has not been treated 




Figure 12. Computed colony forming units of S. agnetis 1379 following treatment with different 
concentrations of gentamicin sulphate over a 5-hour period. The control has not been treated 
with gentamicin and is indicated with a solid blue line.  
3.3.2. Results of crystal violet assay  
Figure 13. Compilation of data from multiple trials of crystal violet assays. Each sample was run 
in triplicates. (Left) Mean optical density readings of HTCs infected with S. agnetis 908, 1379 
and HTC control; (Centre) OD readings of S. agnetis 1379 infected HTCs compared with HTC 
control; (Right) OD readings of S. agnetis 908 infected HTCs compared with HTC control. Error 
bars represent standard deviations (n=3). 
The optical density readings correlate to the number of viable HTCs in each sample. The 
HTCs on the control wells proliferated exponentially during the three day period while the HTCs 




is a slight decrease in the number of viable HTCs on the  first day following coculture. 
Interestingly, the wells infected with 1379 show more variabilty in their optical density readings 
unlike 908. In some experiments the 1379 wells have OD readings similar to that of the control 
wells indicating proliferation while in other experiments the OD values were similar to that of the 
908 infected wells.  
The HTC control wells continued to proliferate exponentially since they were uninfected 
and were supplied with ideal growth conditions. The 908 infected HTC cells declined in number 
due to death caused by bacterial invasions. It is clear that during an infection, the HTCs are 
unable to proliferate.  
3.3.3. Results of determining viable cell-associated bacteria.  
Day 0 provides the colony counts of the cell-associated bacteria 4 hours after coculture. 
The results show that approximately 90% of the bacteria that were introduced into the coculture 
had survived the two-hour incubation in gentamicin growth media which suggests that the 
colony counts we obtained by plating the lysate are the intracellular and cell-associated 
bacteria.  
Figure 14. Colony forming units (log scale) determined for the cell-associated bacteria over a 






























There is no significant difference between the cell-associated colony counts for 908 and 
1379 (P>0.05). However, after being exposed to an overnight incubation in gentamicin 
supplemented growth media, the number of cell-associated 908 have significantly decreased (P 
= 0.00675) and continues to remain constant during the next few days while, the cell associated 
bacterial counts for 1379 remain unchanged (Figure 14). It is evident that S. agnetis  1379 has 
more cell associated bacteria remaining at the end of the three-day period (45%) when 
compared to 908 (6%) (Figure 15).  
Figure 15. Percent cell associated bacteria for S. agnetis 908 (Orange) and 1379 (Blue) three 
days after coculture.  
3.3.4. Results of heat-inactivated serum on the crystal violet assay 
The results show that the HTCs in the control wells grow exponentially regardless of the 
type of sera used. Growth rate is highest between day 2 and day 3 (Figure 16). There is no 
significant difference between the heat-inactivated and normal sera groups (P>0.05). The 
infected HTCs lack proliferation and exponential growth, but rather show a reduction on day 1 
following the coculture and there on, remains constant. The only divergent result observed is in 
a single trial where 908 infected HTCs in the normal sera group show an increase in optical 


































Figure 16. Affect of heat-inactivated serum on the viability of HTCs. The mean optical density 
values at 570nm corressponding to HTC control (Green), S. agnetis  908 (Orange) and S. 
agnetis  1379 (Blue). Heat-inactivated serum samples are indicated with triangles while normal 
sera are marked with a circle. HI – Heat-inactivated; NS – Normal Serum  Error bars represent 
standard deviations (n=3) 
3.4. Discussion 
Present day microbiology requires fast and efficient methods to determine bacterial 
counts. A few novel methods used include turbidity, flow cytometry, microscopic methods, and 
impedance measurements (Rasch, 2004). Measure of turbidity or optical density is one common 
method used in many studies. Determining CFU counts through OD readings can be done is a 
variety of ways such as fitting a primary growth curve model to OD data (Dalgaard and 
Koutsoumanis, 2001, Horakova et al., 2004), using calibration curves based on the linear 
relationship between OD and CFU counts based on Beer-Lamberts law to recalculate OD data 
to CFU counts (Jorgensen and Schulz, 1985, Lack et al., 1999) or using logarithmic transformed 




Mott, 1994). The latter has been used in our study to make the standard curves for 908 and 
1379.   
But do optical density values correlate to viable cell counts under stressful conditions? The 
optical density values of 1379 treated with varying concentrations of gentamicin appear to have 
a similar pattern to that of the untreated control group. Therefore, OD values alone would not be 
sufficient to determine the susceptibility of a bacterium to an antibiotic. This is because OD 
readings are not always an accurate representation of viable cell counts especially when the 
bacteria are subjected to stress. Antibiotics such as gentamicin used in our experiment, induce 
stress in bacterial cells. Exposure to stressful conditions has been shown to cause modifications 
in bacterial cell structure (Cefali et al., 2002). When this is the case, the relationship between 
logarithmic transformations of OD and CFU/mL can result in discrepancies (Francois et al., 
2006, Jorgensen and Schulz, 1985, Chorin et al., 1997). Instead, it could reflect the size and 
shape of the bacterial isolates as well (Udekwu et al., 2009). We have observed that S. agnetis 
1379 undergoes autolysis during storage in 4OC. We hypothesize that this could be a response 
to cold stress. However, we have not tested this. It is possible that stress brought by the 
antibiotic could affect 1379 in a manner that cell death does not correlate to a decrease in OD 
readings. Instead, it could potentially have similar cell densities to the control 1379 that has not 
been treated with antibiotics. Since we obtained respective CFU data using the standard curve it 
is impossible to interpret the MIC for S. agnetis due to discrepancies between the OD readings 
and CFU counts. This emphasizes the need to determine the viable bacterial counts through the 
traditional plating method in order to obtain accurate and reliable results especially when testing 
the susceptibility of a bacterium to antibiotic.   
We do not observe exponential growth in our experiment. According to CLSI guidelines 
(Wilker, 2005), the requirements to determine the minimum inhibitory concentration (MIC), 
consists of media inoculated with cultures adjusted to yield ∼5 × 105 cells/mL, allowed to grow 




during a short period using optical density (Udekwu et al., 2009). However, the starting number 
of bacteria in our experiment was approximately 1x108 CFU/mL. Furthermore, our bacterial 
populations were at their stationary phase during the experiment and as a result, we are unable 
to observe an exponential growth making it difficult to come to interpret antibiotic sensitivity 
results.  
The results of our optimized crystal violet assay show that staining eukaryotic cells such 
as HTCs with 0.5% crystal violet is an effective and efficient method to quantify the viable 
eukaryotic cells.  All infected HTCs decrease in number on day 1 (one day following coculture) 
and remain at a constant level as indicated by the optical density values. This decrease in HTCs 
could be caused by by cell death induced by the bacterial invasion. Cell death can be caused by 
apoptosis, programmed necrosis, and pyroptosis (Mitchell et al., 2016) however, our experiment 
does not provide data to determine the mechanism of cell death. Through our results it is clear 
that the bacterial infected HTCs undergo cell death during the first day following infection as 
observed by the reduction in optical density values on day 2, and are unable to recover and 
proliferate. This suggests that the HTCs are possibly battling viable intracellular bacteria.  
Additionally, this assay has also highlighted the downsides of antibiotic protection 
assays.  Antibiotic protection assays allow for the study of intracellular bacterial virulence 
mechanisms by eliminating and limiting extracellular bacteria (Tabrizi and Robinsbrowne, 1993). 
The antibiotic selected for this purpose should be sufficiently potent to kill the extracellular 
bacteria but also be impermeable to the host cell. Gentamicin which we have used in our assay 
and streptomycin has been widely used in antibiotic protection assays by many studies because 
they possess these abilities.  
However, recent literature have raised concerns on the use of antibiotic protection 
assays due to findings that the antibiotics such as gentamicin could in fact penetrate eukaryotic 
cells over time and accumulate enough to kill intracellular bacteria (VanCleave et al., 2017, 




through the variability in the results of our experiment. Through out the various trials, the OD 
values reflecting the viable HTCs in the wells infected with 1379, show fluctuations. One 
possible explanation for this is the prolonged exposure to a high (50ug/mL) of gentamicin.  
According of Drevets et al. (1994) and Hamrick et al. (2003), intracellular bacteria 
compartmentalized with in vacuoles such as phagosomes are more susceptile to being inhibited 
by aminoglycosides. When exposed for a prolonged duration, aminoglycosides such as 
Gentamicin in the extracellular space is taken up by the eukaryotic cell through pinocytosis. The 
antibiotic, now contained within the vescicle is more likely to fuse with the other vacuoles such 
as phagosomes resulting in the death of bacteria contained within it (Flannagan et al., 2016).  
Bacteria such as Staphylococcus agnetis are engulfed by macrophages and contained 
with phagosomes where they are killed by hydolytic enzymes, acidic pH, Reactive Oxygen 
Species (ROS) and Reactive Nitrogen Species (RNS), lack of nutrients and Adenosine 
Monophosphate (AMPs) (Pidwill et al., 2021). It is possible that majority of the S. agnetis  in our 
study are contained within these phagosomes as well. Thus, we speculate gentamicin had 
enetered the HTCs during the course of our three day experiment and implemented their 
bactericidal effects on the internalized bacteria.  
Furthermore, many studies suggest the use of a low concentration of gentamicin such as 
5µg/mL for a prologed duration or a higher concentration for a shorter duration. In their study 
Hamrick et al. (2003) describes that despite the use of 5µg/mL of gentamicin for 4 hours, 
gentamicin had managed to enter the eukaryotic host cell and kill intracellular bateria. Our study 
used 50µg/mL of gentamicin for three days which would definitely have caused gentamicin to 
enter HTCs. This would have influenced the intracellular baterial counts which could explain the 
variability of our results especially in HTCs infected with S. agnetis  1379.  
The current data is not sufficient to explain why 1379 is more susceptible to inconsisttent 
results. It is possible that S. agnetis  1379 could be more susceptible to internalized gentamicin 




agnetis  with in a macrophage. It is also possible that the location of the engulfed bacteria would 
influence their susceptibility to gentamicin based on whether they are within phagosomes or 
have managed to evade phagosomes and remain in cytoplasm. Further studies such as 
observation of fluorescent labelled bacteria are required to understand the bactericidal affects of 
internalized gentamicin on the different strains of S. agnetis  in order to explain the inconsistent 
resuts observed for S. agnetis  1379.  
It is possible that intracellular bacteria contributes to the majority of the cell-associated 
bacteria since the gentamicin supplemented growth media should kill any extracellular bacteria. 
Following this assumption, it appears that 1379 persists with in the intracellular space of the 
macrophage as reflected by it’s unchanging colony counts. In contrast, S. agnetis  908 seem to 
be susceptible to the killing mechanisms of the macrophage. 
However, it should be noted that the downsides of a prolonged exposure to gentamicin 
may have an affect on these results. As mentioned before, it is possible that gentamicin had 
entered the intracellular space of the HTCs and influenced the colony counts. If S. agnetis  1379 
is less susceptible to gentamicin it could have contributed to 1379’s intracellular survival. 
Furthermore, the location of 1379 with in the macrophage would too have contributed to the final 
result since gentamicin is known to enetr cells via pinocytosis which would mean the 
pinocytostic vescicle has a greater chance of fusing with the phagosome. If 1379 escapes 
phagosomes and remain in the cytosol it would be less susceptible to the affects of intracellular 
gentamicin.  
The HTCs in the control wells were provided with ideal growth conditions that supported 
their survival and proliferation as reflected by the increasing optical density values. However, it 
is evident through our results that heat inactivating FBS does not have an affect in which HTCs 
grow and proliferate. In contrast to several studies (Soltis et al., 1979, Giard, 1987) using heat-
inactivated FBS did not negatively or positively impact HTC adherence or proliferation. 




Normal FBS contain several complement proteins that would enhance host immune responses. 
This could lead to the assumption that using heat-inactivated serum would in fact cause more 
host cell damage due to the lack of complement proteins and immunoglobulins. Yet, our results 
reveal that the damage inflicted on HTCs by the bacteria are not different between the heat-
inactivated FBS group and normal FBS group. This supports studies that suggest heat 
inactivating serum is not a requirement to maintain cell cultures nor would it interfere with 
coculture results. It does not appear to have a benefit in supporting bacterial survival as 
reflected through the number of viable HTCs.  
However, in one of our trials, HTCs infected with S. agnetis  908 supplemented with 
heat-inactivated FBS showed increasing OD readings two days after infection. This could be an 
anomaly and can be due to the negative effects of prolonged exposure to a high concentration 
of gentamicin. As explained in the previous section, even though gentamicin has been thought 
to be impermeable to eukaryotic cells, several studies have revealed that it does in fact enter 
eukaryotic cells and could kill intracellular bacteria (VanCleave et al., 2017, Drevets et al., 1994, 
Ohya et al., 1998, Eze et al., 2000, Hamrick et al., 2003). It is possible that the vvariations 
observed in our results are due to the downsides of gentamicin protect assays.  
3.5. References 
ATCC.ORG. 2021. ATCC - Purpose of heat-inactivating serum-154. [online] Available at: 
<https://www.atcc.org/support/faqs/ff985/Purpose+of+heat-inactivating+serum-
154.aspx> [Accessed 16 May 2021]. 
BEGANOVIC, M., LUTHER, M. K., RICE, L. B., ARIAS, C. A., RYBAK, M. J. & LAPLANTE, K. 
L. 2018. A Review of Combination Antimicrobial Therapy for Enterococcus faecalis 
Bloodstream Infections and Infective Endocarditis. Clinical Infectious Diseases, 67, 303-
309. 
CEFALI, E., PATANE, S., ARENA, A., SAITTA, G., GUGLIELMINO, S., CAPPELLO, S., 
NICOLO, M. & ALLEGRINI, M. 2002. Morphologic variations in bacteria under stress 
conditions: Near-field optical studies. Scanning, 24, 274-283. 
CHORIN, E., THUAULT, D., CLERET, J. J. & BOURGEOIS, C. M. 1997. Modelling Bacillus 




DALGAARD, P. & KOUTSOUMANIS, K. 2001. Comparison of maximum specific growth rates 
and lag times estimated from absorbance and viable count data by different 
mathematical models. Journal of Microbiological Methods, 43, 183-196. 
DREVETS, D. A., CANONO, B. P., LEENEN, P. J. M. & CAMPBELL, P. A. 1994. GENTAMICIN 
KILLS INTRACELLULAR LISTERIA-MONOCYTOGENES. Infection and Immunity, 62, 
2222-2228. 
ERNST, R. K., GUINA, T. & MILLER, S. I. 1999. How intracellular bacteria survive: Surface 
modifications that promote resistance to host innate immune responses. Journal of 
Infectious Diseases, 179, S326-S330. 
EVEN, M. S., SANDUSKY, C. B. & BARNARD, N. D. 2006. Serum-free hybridoma culture: 
ethical, scientific and safety considerations. Trends in Biotechnology, 24, 105-108. 
EZE, M. O., YUAN, L., CRAWFORD, R. M., PARANAVITANA, C. M., HADFIELD, T. L., 
BHATTACHARJEE, A. K., WARREN, R. L. & HOOVER, D. L. 2000. Effects of 
opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse 
peritoneal macrophages in vitro. Infection and Immunity, 68, 257-263. 
FANTE, M. A., DECKING, S. M., BRUSS, C., SCHREML, S., SISKA, P. J., KREUTZ, M. & 
RENNER, K. 2021. Heat-Inactivation of Human Serum Destroys C1 Inhibitor, Pro-motes 
Immune Complex Formation, and Improves Human T Cell Function. International 
Journal of Molecular Sciences, 22. 
FLANNAGAN, R. S., HEIT, B. & HEINRICHS, D. E. 2016. Intracellular replication of 
Staphylococcus aureus in mature phagolysosomes in macrophages precedes host cell 
death, and bacterial escape and dissemination. Cellular Microbiology, 18, 514-535. 
FRANCOIS, K., DEVLIEGHERE, F., STANDAERT, A. R., GEERAERD, A. H., VAN IMPE, J. F. 
& DEBEVERE, J. 2006. Effect of environmental parameters (temperature, pH and a(w)) 
on the individual cell lag phase and generation time of Listeria monocytogenes. 
International Journal of Food Microbiology, 108, 326-335. 
GIARD, D. J. 1987. ROUTINE HEAT INACTIVATION OF SERUM REDUCES ITS CAPACITY 
TO PROMOTE CELL ATTACHMENT. In Vitro Cellular & Developmental Biology, 23, 
691-697. 
HAMRICK, T. S., DIAZ, A. H., HAVELL, E. A., HORTON, J. R. & ORNDORFF, P. E. 2003. 
Influence of extracellular bactericidal agents on bacteria within macrophages. Infection 
and Immunity, 71, 1016-1019. 
HORAKOVA, K., GREIFOVA, M., SEEMANNOVA, Z., GONDOVA, B. & WYATT, G. M. 2004. A 
comparison of the traditional method of counting viable cells and a quick microplate 
method for monitoring the growth characteristics of Listeria monocytogenes. Letters in 
Applied Microbiology, 38, 181-184. 
HUDSON, J. A. & MOTT, S. J. 1994. COMPARISON OF LAG TIMES OBTAINED FROM 
OPTICAL-DENSITY AND VIABLE COUNT DATA FOR A STRAIN OF 




JOHNSON, M., 2012. Fetal Bovine Serum. Materials and Methods, 2. 
JORGENSEN, H. L. & SCHULZ, E. 1985. TURBIDIMETRIC MEASUREMENT AS A RAPID 
METHOD FOR THE DETERMINATION OF THE BACTERIOLOGICAL QUALITY OF 
MINCED MEAT. International Journal of Food Microbiology, 2, 177-183. 
KAWAKAMI, T., KAWAMURA, K., FUJIMORI, K., KOIKE, A. & AMANO, F. 2016. Influence of 
the culture medium on the production of nitric oxide and expression of inducible nitric 
oxide synthase by activated macrophages in vitro. Biochemistry and biophysics reports, 
5, 328-334. 
KOHANSKI, M. A., DWYER, D. J., HAYETE, B., LAWRENCE, C. A. & COLLINS, J. J. 2007. A 
common mechanism of cellular death induced by bactericidal antibiotics. Cell, 130, 797-
810. 
LACK, W. K., BECKER, B., KRAMER, J. & HOLZAPFEL, W. H. 1999. Turbidimetry as a rapid 
method for enumeration of microorganisms in raw vegetables. Archiv Fur 
Lebensmittelhygiene, 50, 136-140. 
MEKALANOS, J. J. 1992. ENVIRONMENTAL SIGNALS CONTROLLING EXPRESSION OF 
VIRULENCE DETERMINANTS IN BACTERIA. Journal of Bacteriology, 174, 1-7. 
MITCHELL, G., CHEN, C. & PORTNOY, D. A. 2016. Strategies Used by Bacteria to Grow in 
Macrophages. Microbiology Spectrum, 4. 
OHYA, S., XIONG, H., TANABE, Y., ARAKAWA, M. & MITSUYAMA, M. 1998. Killing 
mechanism of Listeria monocytogenes in activated macrophages as determined by an 
improved assay system. Journal of Medical Microbiology, 47, 211-215. 
PIDWILL, G. R., GIBSON, J. F., COLE, J., RENSHAW, S. A. & FOSTER, S. J. 2021. The Role 
of Macrophages in Staphylococcus aureus Infection. Frontiers in Immunology, 11. 
PIZARROCERDA, J., MORENO, E., DESJARDINS, M. & GORVEL, J. P. 1997. When 
intracellular pathogens invade the frontiers of cell biology and immunology. Histology 
and Histopathology, 12, 1027-1038. 
PRICE, J. V. & VANCE, R. E. 2014. The Macrophage Paradox. Immunity, 41, 685-693. 
ROBERTSON, E., 1987. Teratocarcinomas and embryonic stem cells. Oxford: IRL Press 
SHAH, G. 1999. Why do we still use serum in the production of biopharmaceuticals? 
Developments in biological standardization, 99, 17-22. 
SHARMA, A. & PUHAR, A. 2019. Gentamicin Protection Assay to Determine the Number of 
Intracellular Bacteria during Infection of Human TC7 Intestinal Epithelial Cells by 
Shigella flexneri. Bio-Protocol, 9. 
SOLTIS, R. D., HASZ, D., MORRIS, M. J. & WILSON, I. D. 1979. EFFECT OF HEAT 
INACTIVATION OF SERUM ON AGGREGATION OF IMMUNOGLOBULINS. 




TABRIZI, S. N. & ROBINSBROWNE, R. M. 1993. ELIMINATION OF EXTRACELLULAR 
BACTERIA BY ANTIBIOTICS IN QUANTITATIVE ASSAYS OF BACTERIAL 
INGESTION AND KILLING BY PHAGOCYTES. Journal of Immunological Methods, 158, 
201-206. 
THI, E. P., LAMBERTZ, U. & REINER, N. E. 2012. Sleeping with the Enemy: How Intracellular 
Pathogens Cope with a Macrophage Lifestyle. Plos Pathogens, 8. 
TRIGLIA, R. P. & LINSCOTT, W. D. 1980. TITERS OF 9 COMPLEMENT COMPONENTS, 
CONGLUTININ AND C3B-INACTIVATOR IN ADULT AND FETAL BOVINE SERA. 
Molecular Immunology, 17, 741-748. 
UDEKWU, K. I., PARRISH, N., ANKOMAH, P., BAQUERO, F. & LEVIN, B. R. 2009. Functional 
relationship between bacterial cell density and the efficacy of antibiotics. Journal of 
Antimicrobial Chemotherapy, 63, 745-757. 
UNIVERSITY OF KANSAS MEDICAL CENTER (2021). Crystal Violet Assay. Available at 
:<http://www2.kumc.edu/soalab/LabLinks/protocols/cvassay.htm> [Accessed 15 
February 2021]. 
VANCLEAVE, T. T., PULSIFER, A. R., CONNOR, M. G., WARAWA, J. M. & LAWRENZ, M. B. 
2017. Impact of Gentamicin Concentration and Exposure Time on Intracellular Yersinia 
pestis. Frontiers in Cellular and Infection Microbiology, 7. 
WEISS, S., WHITFORD, W., GORFIEN, S. AND GODWIN, G., n.d. Insect Cell-Culture 







Enzyme Protection Assay 
4.1. Introduction 
Antibiotic Protection assays make use of the bactericidal properties of antibiotics such as 
that of the aminoglycoside gentamicin, to eliminate extracellular bacteria, to assess survival of 
only intracellular bacteria. Due to their large size and negative charge (Tulkens, 1991), it is 
believed that these antibiotics cannot permeate eukarytoic cells. However, recent studies have 
showed that gentamicin is capable of penetrating eukarytoic cells and affecting intracellular 
bacterial viability (VanCleave et al., 2017, Drevets et al., 1994, Ohya et al., 1998, Eze et al., 
2000, Hamrick et al., 2003). Furthermore, it is possible that gentamicin may fail to completely 
eliminate extrcellular bacteria depending on the antibiotic sensitivity of the particular bacterial 
species. This may compromise the accuracy of gentamicin protection assays.  
To overcome these drawbacks, an alternative technique using cell wall degrading 
enzymes, termed as Enzyme Protection Assay (EPA), was investigated.  
4.1.1. What is an Enzyme Protection Assay? 
EPA makes use of enzymes that are lethal to the bacteria of interest. The enzymes used 
for EPA should not be able to cross the eukaryotic cell membrane thereby, it would only 
eliminate extracellular bacteria. The principle is similar to that of Gentamicin Protection Assays 
(GPAs)  (Sharma, 2019; Vancleave, 2017) 
Lysostaphin is one such enzyme commonly used in studies that involve Staphylococcus 
species. Lysostaphin was first discovered by (Schindler and Schuhardt, 1964) during 
transduction experiment involving Staphylococcus aureus. They observed a white colony 
srrounded by a zone of inhibition on a lawn of S. aureus bacteria. Upon further experimentation 




genus that had been exposed to Blair type phage no. 6. Through experiments the bacteriolytic 
substance produced by K-6-WI had been isolated and revealed to be the potent bacteriolytic 
agent, lysostaphin.  Due to its rapid rate-of-kill exceeding that of viruent bacteriophages, and 
ability to destroy many phage-types of Staphylococcus aureus, lysostaphin has not been 
categorized as a bacteriophage lysis enzyme. Nor is it categorized as a lysozyme of bacterial 
origin, since it does not display the same antibacterial properties against the Gram-positive 
Micrococcus lysodeikticus (Salton, 1952) or Gram-negative organisms that are generally 
susceptible to lysozyme action (Warren et al., 1955). In addition, it is potent against all 
Staphylococci regardless of their coagulase production whereas a lysozyme it would only be 
potent against coagulase negative strains (Kern et al., 1951) 
Lysostaphin is a a glycylglycine endopeptidase, which acts on Staphylococci and other 
gram-positive bacteria by cleaving the pentaglycine cross bridges of the peptidoglycan cell wall 
(Wu et al., 2003). The enzymatic activity of lysostaphin is highly efficient, where 2 U (units) of 
lysostaphin for 5 minutes is sufficient to emilminate several methicillin-sensitive and methicillin-
susceptible S. aureus strains (Kim et al., 2019).  
Lysostaphin has been identified for having strong bactericidal properties. It is potent 
against more than 50 strains of Staphylococcus species. Yet, does not have an affect on 27 
other species including Streptococcus faecalis, Escherichia coli and Klebsiella pneumoniae 
(Schindler and Schuhardt, 1964). The potency and strength of it’s bacteridical effect has been 
described as more powerful than long term exposure to high concentrations of oxacillin, 
vancomycin and clindamycin. Furthermore, it was efficient enough to disrupt biofilms of S. 
aureus and Streptococcus epidermidis (Wu et al., 2003).  
4.1.2. Advantages of EPA over GPA 
EPA has yielded better results in accurately enumerating the internalization capacity of 




to GPA (Sharma and Puhar, 2019, VanCleave et al., 2017). EPA had an advantage especially 
when measuring bacterial kinetics where the bactericidal agent should be able to eliminate 
bacteria with in a short time. Since gentamicin takes a longer time to kill the extracellular 
bacteria, GPA results may not provide consistent results. However, the biggest advantage of the 
EPA is that it does not alter or influence the intracellular bacterial counts. Even though 
lysostaphin may permeate eukarytotic host cells. It has been identified that any internalized 
lysotaphin is inactivated due to the enzymes unstable nature (Kim et al., 2019). The host cell 
such as macrophages are capable to degrading and modifying the internalized lysostaphin, 
thereby preventing it from killing intracellular bacteria.  
One of the few disadvantages of the EPA is that it involves an enzyme, therefore the 
physiological conditions of the assay should be controlled to maintain an optimum pH and 
temperature (Yokogawa et al., 1975).  
4.2. Materials and methods 
4.2.1. Measuring sensitivity of Staphylococcus agnetis 908 and 1379 to lysostaphin 
We selected 2 U/mL of lysostophin as the concentration for our experiment (Kim et al). 
In brief, 2x105 cells/mL of S. agentis 908 and 1379 were prepared in RPMI 1640 growth media 
supplemented with sodium pyruvate, 2-mercaptoethanol and Glutamax. Lysostaphin 
(BioVendor, LLC, Asheville, NC) was added as 0.64 ul of 3 mg/ml (12,411 U/ml) stock solution 
to the bacterial suspensions to achieve 2 U/ml of lysostaphin. The bacterial suspensions were 
then incubated for two hours with OD650 recorded every 30 minutes and viable colony counts 







4.2.2. Crystal Violet Assay to determine viable HTCs.  
To compare the efficacy of the Enzyme Protection Assay (EPA) we used the Crystal 
Violet (CV) assay on S. agnetis 908, 1379 and transformant of 1379: 1589A, which was 
confirmed to contain the A164E substitution through sequence data (see Chapter 2).  
The wells were stained with 0.5% crystal violet according to the CV assay protocol 
described in Chapter 3 to determine the viable HTCs after cocululture. To ennumerate the cell-
associated bacteria, the HTCs were lysed with 0.5mL of sterile distilled water. The lysate was 
then plated on TS agar plates and incubated overnight in 37o-C.  
The experiment was carried out over a three day period. Each sample was performed in 
triplicates.  Day-0 samples were processed six hours post coculture (four hours of phagocytosis 
and two hour incubation time in lysostaphin growth media). Wells allocated for days 1 to 3 were 
replaced with 0.5 mL of fresh RPMI growth media with 2 U of lysostaphin each day.  
4.3. Results 
4.3.1. Measuring sensitivity to lysostaphin  
The colony counts reveal that it takes, two hours for 2 U of lysostaphin to fully eliminate 
908 while 1379 is killed with in 30 minutes of exposure to lysostaphin (Figure 17) indicating that 
1379 is more susceptible to killing by lysostaphin.  But overall, it is evident that both S. agnetis 




Figure 17. Susceptibility of S. agnetis 908 and 1379 to 2 U/mL of lysostaphin measured during 
a two-hour period. The colony counts are in log scale.  
 
In order to determine whether a higher lysostaphin concentration would decrease time 
taken to eliminate S. agnetis 908, we repeated the experiment using 6 U/mL of lysostaphin 
(Figure 18). However, increasing the concentration of lysostaphin did not reduce the killing time 
as shown by figure. Instead similar to results with 2 U/mL concentration, it took 6 U lysostaphin 
two hours to eliminate 908 which indicates that 908’s susceptibilty to lysostaphin is 
concentration independent.  
Figure 18. Susceptibility of S. agnetis 908 to 2 U (orange) and 6 U(blue) of lysostaphin as 


























































4.3.2. Crystal Violet Assay paired with EPA. 
In Chapter 3, CV assay with GPA revealed that HTCs infected with S. agnetis 908 and 
the transformant 1589A did not proliferate during the three-day period while the HTCs infected 
with S. agnetis 1379 proliferated in a manner similar to the uninfected HTC control  
(Figure 19). However, when CV assay was paired with EPA the results were different. The OD 
readings revealed that all three strains affected the HTC viability in a similar manner. HTC 
proliferation was observed only in the uninfected control group.  
Figure 19. Comparison of CV assay results obtained through GPA (left) and EPA (right). Error 
bars represent standard deviations (n=3).  
To further confirm these results, we lysed the HTCs on day-3 to enumerate the cell-
associated bacteria. The results obtained through the GPA revealed that S. agnetis 1379 has 
the highest number of cell-associated bacteria while 908 and the transformant have fewer 
bacteria three days post-infection (Figure 20). However, when EPA was used, only the 
transformant showed a significant decrease in bacterial cell counts on day 3, with no significant 





Figure 20. Cell counts of cell-associated bacteria in Colony Forming Units (CFU/mL) of the 
three strains 1379, 908 and 1589A on day-3 of the GPA (Left) and EPA (Right). Error bars 
represent standard deviations (n=3).  
 
4.4. Discussion 
4.4.1. Measuring sensitivity to lysostaphin  
Previous literature have identified almost 50 strains of Staphylococci including methicillin 
resistant strains are susceptible to lysostaphin (Schindler and Schuhardt, 1964, Kim et al., 2019, 
Easmon et al., 1978). However, to our knowledge, no study had previously determined the 
sensitivity of Staphylococcus agnetis. Our findings have shown that both strains of S. agnetis, 
908 and 1379, are susceptible to lysostophin.  However, in order to eliminate S. agnetis 908 
completely, a two hour incubation in 2 U of lysostaphin was required.   
The results of our time-kill assay revealed that the sensitivity of 908 to lysostaphin was 
concentration independent. This contrasts with Kim et al. (2019) where  three methicillin-
resistant strains of S. aureus were eliminated rapidly when incubated with 2 U (17.6 nM) of 
lysostaphin instead of 1 U (8.8 nM). It is possible that 908 could be rapidly eliminated using 






4.4.2. Crystal Violet Assay paired with Enzyme Protection Assay 
The findings of our study corroborate previous literature that describe the advantages of 
EPA over GPA (Kim et al., 2019). The CV assay reflects the benefits of the EPA clearly with the 
consistent results. As explained in the previous chapter, CV assays that were carried out using 
GPA yielded inconsistent results with 1379 showing variability. When we compared results 
using EPA, it was clear that gentamicin had influenced the CV assay results by permeating the 
host cell. We observed that S. agnetis 1379 infected HTCs show recovery and proliferation 
when paired with GPA. It is possible that 1379 resides in the cytosolic space of macrophages 
thereby managing to evade the bactericidal effects of gentamicin encased in vacuoles 
(Flannagan et al., 2016). This would have provided 1379 with a safe niche to remain viable 
within the macrophages as indicated by the higher colony counts for 1379.  
The reduction in the number of HTCs are caused by damage inflicted to macrophages 
by bacteria, during which the bacteria would rupture the macrophage either through 
programmed cell death or simple escape, resulting in a reduction in viable HTCs (Mitchell et al., 
2016, Ross, 2001, Lamkanfi and Dixit, 2010). Through previous work we have found that 908 is 
capable of surviving or escaping macrophages better than 1379 (Zaki, 2021). The phagocytosis 
assays used in the study involved an overnight incubation in 50 µg/mL of gentamicin 
supplemented growth media where gentamicin could have permeated the HTCs. The results we 
observed following the gentamicin incubation were identical to the results we quantified through 
CV assay with more viable HTCs present in 1379 while less viable HTCs in 908 infected wells. It 
is possible that gentamicin is influencing 1379 escape from macrophages. However, we have 
not tested for this assumption. But this could explain why 908 continued to damage HTCs 
resulting in reduced OD readings in the CV assay and low colony counts obtained on day 3. 
Further studies using fluorescent labelled bacteria and HTCs would help understand this 




The EPA has provided evidence that all three strains of S. agnetis including the 
transformant 1589A, cause equal damage to the host HTCs. Therefore, we conclude that this 
experiment does not provide sufficient data to support the hypothesis that A164E in the deoC 
gene is responsible for the increased escape and survival observed in 908. Furthermore, our 
results seem to indicate that S. agnetis 908 and 1379 may have differential response to 
gentamicin which was reflected through the phagocytosis assays paired with GPA. However, 
further studies are needed to test this hypothesis.  
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Figure 21. The standard curve used in determining the colony counts for S. agnetis 908 and 1379 based on their optical density 
values 
 
y = 8E+08x + 286105

































RPMI 1640 growth media supplemented with antibiotics and antibiotics.  
(All volumes for adjusted for 250 mL of media): 
• 2.5 mL Sodium pyruvate 100x  
• 227 µl Beta-mercaptoethanol (sterile)  
• 2.5 mL L-Glutamax 100x  
• 25 mL 10% fetal bovine serum (low-endotoxin)  
• 217 mL RPMI 1640 (Without L-glutamine)  
• 2.5 mL 100x Antibiotic-antimycotic solution 
• 50 µl of gentamicin sulphate solution   
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